Literature DB >> 24670178

Abatacept in B7-1-positive proteinuric kidney disease.

Anna Greka, Astrid Weins, Peter Mundel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24670178      PMCID： PMC5176021          DOI： 10.1056/NEJMc1400502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

Review 2.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Structural basis of integrin activation by talin.

Authors:  Kate L Wegener; Anthony W Partridge; Jaewon Han; Andrew R Pickford; Robert C Liddington; Mark H Ginsberg; Iain D Campbell
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 4.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

5.  The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18.

Authors:  Vineet Gupta; Annette Gylling; José Luis Alonso; Takashi Sugimori; Petre Ianakiev; Jiang-Ping Xiong; M Amin Arnaout
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

Review 6.  Cell biology and pathology of podocytes.

Authors:  Anna Greka; Peter Mundel
Journal:  Annu Rev Physiol       Date:  2011-11-04       Impact factor: 19.318

Review 7.  New therapies for treatment of rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Marcus Koeller; Michael H Weisman; Paul Emery
Journal:  Lancet       Date:  2007-12-01       Impact factor: 79.321

8.  Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Authors:  Jochen Reiser; Gero von Gersdorff; Martin Loos; Jun Oh; Katsuhiko Asanuma; Laura Giardino; Maria Pia Rastaldi; Novella Calvaresi; Haruko Watanabe; Karin Schwarz; Christian Faul; Matthias Kretzler; Anne Davidson; Hikaru Sugimoto; Raghu Kalluri; Arlene H Sharpe; Jordan A Kreidberg; Peter Mundel
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

Review 10.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527
View more
  6 in total

Review 1.  Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.

Authors:  Peter Mundel; Anna Greka
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

2.  B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway.

Authors:  Jiemei Li; Jing Niu; Wenjian Min; Jun Ai; Xu Lin; Jinhua Miao; Shan Zhou; Ye Liang; Shuangqin Chen; Qian Ren; Kunyu Shen; Qinyu Wu; Xiaolong Li; Weiwei Shen; Fan Fan Hou; Youhua Liu; Peng Yang; Lili Zhou
Journal:  Cell Death Differ       Date:  2022-06-16       Impact factor: 15.828

3.  Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.

Authors:  George W Burke; Jayanthi Chandar; Junichiro Sageshima; Mariella Ortigosa-Goggins; Pooja Amarapurkar; Alla Mitrofanova; Marissa J Defreitas; Chryso P Katsoufis; Wacharee Seeherunvong; Alexandra Centeno; Javier Pagan; Lumen A Mendez-Castaner; Adela D Mattiazzi; Warren L Kupin; Giselle Guerra; Linda J Chen; Mahmoud Morsi; Jose M G Figueiro; Rodrigo Vianna; Carolyn L Abitbol; David Roth; Alessia Fornoni; Phillip Ruiz; Gaetano Ciancio; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.714

4.  IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.

Authors:  Abigail C Lay; Lorna J Hale; Holly Stowell-Connolly; Robert J P Pope; Viji Nair; Wenjun Ju; Eva Marquez; Ruth Rollason; Jenny A Hurcombe; Bryony Hayes; Timothy Roberts; Lawrence Gillam; Jonathan Allington; Robert G Nelson; Matthias Kretzler; Jeff M P Holly; Claire M Perks; Craig A McArdle; Gavin I Welsh; Richard J M Coward
Journal:  Diabetologia       Date:  2021-03-24       Impact factor: 10.460

Review 5.  Nephrin Signaling in the Podocyte: An Updated View of Signal Regulation at the Slit Diaphragm and Beyond.

Authors:  Claire E Martin; Nina Jones
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-05       Impact factor: 5.555

6.  The immune cell landscape of peripheral blood mononuclear cells from PNS patients.

Authors:  Qing Ye; Chao Zhou; Sisi Li; Jingjing Wang; Fei Liu; Zhixia Liu; Jianhua Mao; Haidong Fu
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.